ArticleGynecologic oncology reports2021

Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy.

Takashi Uehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.